Recurrence of invasive breast cancer could arise from the residual cancer cells after comprehensive treatment.The residual cancer cells are able to form highly patterned vasculogenic mimicry (VM) channels,finally leading to the relapse and metastasis of cancers.In the present study, a new type of targeting vincristine plus dasatinib liposomes was developed for elimination of invasive cancer cells along with the VM channels.